Skip to Main Content

February 2016    Volume 9 Issue 2
Journal of Health and Life Sciences Law

To Promote or Not to Promote? The Enforceability of FDA’s Off-Label Marketing Restrictions Following Amarin

  • February 01, 2016
  • Matthew T. Newcomer , Post & Schell, P.C.
  • Yune T. Do , Post & Schell, P.C.
Share this:

You must be logged in to access this content.

Log in